Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

The tendency of reduced periodontal destruction in acromegalic patients showing similar inflammatory status with periodontitis patients.

Ozdemir Y, Keceli HG, Helvaci N, Erbas T, Nohutcu RM.

Endocrine. 2019 Sep 2. doi: 10.1007/s12020-019-02060-2. [Epub ahead of print]

PMID:
31478163
2.

A case of atypical macroprolactinoma presenting with pituitary apoplexy during pregnancy and review of the literature.

Oguz SH, Soylemezoglu F, Dagdelen S, Erbas T.

Gynecol Endocrinol. 2019 Aug 7:1-8. doi: 10.1080/09513590.2019.1650339. [Epub ahead of print]

PMID:
31389277
3.

Hyperprolactinaemia associated with giant uterine myoma, description of a case and review of literature.

Sendur SN, Aktoz F, Usubutun A, Tuncer ZS, Erbas T.

J Obstet Gynaecol. 2019 Oct;39(7):1034-1036. doi: 10.1080/01443615.2019.1587596. Epub 2019 Jun 14. No abstract available.

PMID:
31195872
4.

A case of Woodhouse-Sakati syndrome with pituitary iron deposition, cardiac and intestinal anomalies, with a novel mutation in DCAF17.

Sendur SN, Oguz S, Utine GE, Dagdelen S, Oguz KK, Erbas T, Alikasifoglu M.

Eur J Med Genet. 2019 Aug;62(8):103687. doi: 10.1016/j.ejmg.2019.103687. Epub 2019 May 29.

PMID:
31152917
5.

Assessment of static and dynamic plantar data of patients with acromegaly.

Sendur SN, Oguz S, Dagdelen S, Erbas T.

Pituitary. 2019 Aug;22(4):373-380. doi: 10.1007/s11102-019-00964-w.

PMID:
31025226
6.

Relation of RANKL and OPG Levels with Bone Resorption in Patients with Acromegaly and Prolactinoma.

Ozer FF, Dagdelen S, Erbas T.

Horm Metab Res. 2018 Jul;50(7):562-567. doi: 10.1055/a-0630-1529. Epub 2018 Jun 12.

PMID:
29895074
7.

Unusual presentations of Carney Complex in patient with a novel PRKAR1A mutation.

Akin S, Noyan S, Dagdelen S, Pasaoglu I, Kaynaroglu V, Askun MM, Bilen CY, Kiratli H, Baydar DE, Onder S, Sokmensuer C, Aytemir K, Erkin G, Kiratli PO, Alikasifoglu M, Erbas T.

Neuro Endocrinol Lett. 2017 Aug;38(4):248-254.

PMID:
28871709
8.

Association between ACE and AGT polymorphism and cardiovascular risk in acromegalic patients.

Erbas T, Cinar N, Dagdelen S, Gedik A, Yorgun H, Canpolat U, Kabakci G, Alikasifoglu M.

Pituitary. 2017 Oct;20(5):569-577. doi: 10.1007/s11102-017-0819-5.

PMID:
28712073
9.

Genetic Alterations in Differentiated Thyroid Cancer Patients with Acromegaly.

Aydin K, Aydin C, Dagdelen S, Tezel GG, Erbas T.

Exp Clin Endocrinol Diabetes. 2016 Mar;124(3):198-202. doi: 10.1055/s-0035-1565061. Epub 2015 Nov 17.

PMID:
26575115
10.

Recurrent parathyroid carcinoma with spinal metastases unresponsive to cinacalcet therapy.

Sendur MA, Dagdelen S, Abbasoglu O, Erbas B, Sokmensuer C, Ziyal I, Erbas T.

J BUON. 2014 Jul-Sep;19(3):863-4. No abstract available.

11.

The clinical and cardiometabolic effects of d3-growth hormone receptor polymorphism in acromegaly.

Cinar N, Dagdelen S, Yorgun H, Canpolat U, Kabakçı G, Erbas T.

Pituitary. 2015 Feb;18(1):116-25. doi: 10.1007/s11102-014-0564-y.

PMID:
24706164
12.

Pituitary adenoma with gangliocytic component: report of 5 cases with focus on immunoprofile of gangliocytic component.

Balci S, Saglam A, Oruckaptan H, Erbas T, Soylemezoglu F.

Pituitary. 2015 Feb;18(1):23-30. doi: 10.1007/s11102-013-0551-8.

PMID:
24430434
13.

Etiology of hypopituitarism in tertiary care institutions in Turkish population: analysis of 773 patients from Pituitary Study Group database.

Tanriverdi F, Dokmetas HS, Kebapcı N, Kilicli F, Atmaca H, Yarman S, Ertorer ME, Erturk E, Bayram F, Tugrul A, Culha C, Cakir M, Mert M, Aydin H, Taskale M, Ersoz N, Canturk Z, Anaforoglu I, Ozkaya M, Oruk G, Hekimsoy Z, Kelestimur F, Erbas T.

Endocrine. 2014 Sep;47(1):198-205. doi: 10.1007/s12020-013-0127-4. Epub 2013 Dec 24.

PMID:
24366641
14.

Diagnosis of acromegaly: role of the internist and the other medical professionals.

Aydin K, Cınar N, Dagdelen S, Erbas T.

Eur J Intern Med. 2014 Feb;25(2):e25-6. doi: 10.1016/j.ejim.2013.09.014. Epub 2013 Oct 21. No abstract available.

PMID:
24157180
15.

Diabetic autonomic neuropathy.

Vinik AI, Erbas T.

Handb Clin Neurol. 2013;117:279-94. doi: 10.1016/B978-0-444-53491-0.00022-5. Review.

PMID:
24095132
16.

Spontaneous remission of acromegaly after infarctive apoplexy with a possible relation to MRI and diabetes mellitus.

Cinar N, Metin Y, Dagdelen S, Ziyal MI, Soylemezoglu F, Erbas T.

Neuro Endocrinol Lett. 2013;34(5):339-42.

PMID:
23922047
17.

Increased thyroid cancer risk in acromegaly.

Dagdelen S, Cinar N, Erbas T.

Pituitary. 2014 Aug;17(4):299-306. doi: 10.1007/s11102-013-0501-5.

PMID:
23836362
18.

Evaluation of thyroid diseases and differentiated thyroid cancer in acromegalic patients.

Dogan S, Atmaca A, Dagdelen S, Erbas B, Erbas T.

Endocrine. 2014 Feb;45(1):114-21. doi: 10.1007/s12020-013-9981-3. Epub 2013 May 14.

PMID:
23670709
19.

Assessment of cardiac autonomic functions by heart rate recovery, heart rate variability and QT dynamicity parameters in patients with acromegaly.

Dural M, Kabakcı G, Cınar N, Erbaş T, Canpolat U, Gürses KM, Tokgözoğlu L, Oto A, Kaya EB, Yorgun H, Sahiner L, Dağdelen S, Aytemir K.

Pituitary. 2014 Apr;17(2):163-70. doi: 10.1007/s11102-013-0482-4.

PMID:
23553172
20.

Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease.

Vinik AI, Erbas T, Casellini CM.

J Diabetes Investig. 2013 Jan;4(1):4-18. Epub 2013 Jan 29.

21.

Voice characteristics of acromegaly.

Aydin K, Turkyilmaz D, Ozturk B, Dagdelen S, Ozgen B, Unal F, Erbas T.

Eur Arch Otorhinolaryngol. 2013 Mar;270(4):1391-6. doi: 10.1007/s00405-013-2369-4. Epub 2013 Feb 7.

PMID:
23389327
22.

Cavernous sinus invasion might be a risk factor for apoplexy.

Cinar N, Tekinel Y, Dagdelen S, Oruckaptan H, Soylemezoglu F, Erbas T.

Pituitary. 2013 Dec;16(4):483-9. doi: 10.1007/s11102-012-0444-2.

PMID:
23179962
23.

Changing clinical characteristics of thyroid carcinoma at a single center from Turkey: before and after the Chernobyl disaster.

Ozdemir D, Dagdelen S, Kiratli P, Tuncel M, Erbas B, Erbas T.

Minerva Endocrinol. 2012 Sep;37(3):267-74.

PMID:
22766893
24.

Functional and structural evaluation of hearing in acromegaly.

Aydin K, Ozturk B, Turkyilmaz MD, Dagdelen S, Ozgen B, Unal F, Erbas T.

Clin Endocrinol (Oxf). 2012 Mar;76(3):415-9. doi: 10.1111/j.1365-2265.2011.04209.x.

PMID:
21883347
25.

Systemic mastocytosis.

Ozdemir D, Dagdelen S, Erbas T.

Am J Med Sci. 2011 Nov;342(5):409-15. doi: 10.1097/MAJ.0b013e3182121131. Review.

PMID:
21629042
26.

Amyloid goiter and hypopituitarism in a patient with systemic amyloidosis.

Ozdemir D, Dagdelen S, Erbas T, Sokmensuer C, Erbas B, Cila A.

Amyloid. 2011 Mar;18(1):32-4. doi: 10.3109/13506129.2010.545961. Epub 2011 Jan 13.

PMID:
21231858
27.

Prevalence of peripheral neuropathy and painful peripheral neuropathy in Turkish diabetic patients.

Erbas T, Ertas M, Yucel A, Keskinaslan A, Senocak M; TURNEP Study Group.

J Clin Neurophysiol. 2011 Feb;28(1):51-5. doi: 10.1097/WNP.0b013e3182051334.

PMID:
21221008
28.

Hypotension, Syncope, and Fever in Systemic Mastocytosis without Skin Infiltration and Rapid Response to Corticosteroid and Cyclosporin: A Case Report.

Ozdemir D, Dagdelen S, Erbas T, Agbaht K, Serefhanoglu S, Aksu S, Ersoy-Evans S.

Case Rep Med. 2010;2010:782595. doi: 10.1155/2010/782595. Epub 2010 Dec 20.

29.

Endocrine involvement in systemic amyloidosis.

Ozdemir D, Dagdelen S, Erbas T.

Endocr Pract. 2010 Nov-Dec;16(6):1056-63. doi: 10.4158/EP10095.RA. Review.

PMID:
20570812
30.

Disease of the Sultans: metabolic syndrome in Ottoman dynasty.

Dağdelen S, Erbaş T.

Anadolu Kardiyol Derg. 2010 Jun;10(3):270-3. doi: 10.5152/akd.2010.069.

31.

Evaluation of the impact of treatment on endothelial function and cardiac performance in acromegaly.

Akgul E, Tokgozoglu SL, Erbas T, Kabakci G, Aytemir K, Haznedaroglu I, Oto A, Kes SS.

Echocardiography. 2010 Sep;27(8):990-6. doi: 10.1111/j.1540-8175.2010.01179.x.

PMID:
20412263
32.

Impact of renin-angiotensin system polymorphisms on renal haemodynamic responsiveness to acute angiotensin-converting enzyme inhibition in type 2 diabetes mellitus.

Volkan-Salanci B, Dagdelen S, Alikasifoglu M, Erbas T, Hayran M, Erbas B.

J Renin Angiotensin Aldosterone Syst. 2009 Mar;10(1):41-50. doi: 10.1177/1470320309102326.

PMID:
19286758
33.

Normal parathyroid hormone levels in a diabetic patient with parathyroid adenoma.

Gulcelik NE, Bozkurt F, Tezel GG, Kaynaroglu V, Erbas T.

Endocrine. 2009 Apr;35(2):147-50. doi: 10.1007/s12020-008-9135-1. Epub 2008 Dec 31.

PMID:
19116787
34.

Pituitary hypoplasia and growth hormone deficiency in a woman with glycogen storage disease type Ia: a case report.

Dagdelen S, Atmaca A, Alikasifoglu A, Erbas T.

J Med Case Rep. 2008 Jun 18;2:210. doi: 10.1186/1752-1947-2-210.

35.

[Global confusion on the diagnostic criteria for metabolic syndrome: what is the point that guidelines can not agree?].

Dağdelen S, Yildirim T, Erbaş T.

Anadolu Kardiyol Derg. 2008 Apr;8(2):149-53. Review. Turkish.

36.

Factor V Leiden mutation and type 1 diabetes mellitus.

Demirer AN, Alikasifoglu M, Tuncbilek E, Karakus S, Erbas T.

Blood Coagul Fibrinolysis. 2008 Jan;19(1):70-4. doi: 10.1097/MBC.0b013e3282f38c5f.

PMID:
18180619
37.

McCune-Albright syndrome associated with acromegaly and bipolar affective disorder.

Ozcan-Kara P, Mahmoudian B, Erbas B, Erbas T.

Eur J Intern Med. 2007 Dec;18(8):600-2. Epub 2007 Aug 27.

PMID:
18054713
38.

Hepatosteatosis with hypobetalipoproteinemia.

Sen D, Dagdelen S, Erbas T.

J Natl Med Assoc. 2007 Mar;99(3):284-6.

39.

Management and in-hospital outcome of patients with first episode of acute myocardial infarction: impact of diabetes mellitus.

Atmaca A, Dogan S, Dagdelen S, Kabakci G, Kes S, Nazli N, Erbas T.

J Natl Med Assoc. 2006 Nov;98(11):1752-7.

40.

Cardiovascular autonomic neuropathy: diagnosis and management.

Vinik AI, Erbas T.

Curr Diab Rep. 2006 Dec;6(6):424-30. Review.

PMID:
17118224
41.
42.

Follow-up of pregnancy in acromegalic women: different presentations and outcomes.

Atmaca A, Dagdelen S, Erbas T.

Exp Clin Endocrinol Diabetes. 2006 Mar;114(3):135-9.

PMID:
16636980
43.

Melatonin levels decrease in type 2 diabetic patients with cardiac autonomic neuropathy.

Tutuncu NB, Batur MK, Yildirir A, Tutuncu T, Deger A, Koray Z, Erbas B, Kabakci G, Aksoyek S, Erbas T.

J Pineal Res. 2005 Aug;39(1):43-9.

PMID:
15978056
44.

Lipoatrophy induced by subcutaneous administration of octreotide in the treatment of acromegaly.

Atmaca A, Erbas T.

Exp Clin Endocrinol Diabetes. 2005 Jun;113(6):340-3.

PMID:
15977102
45.
46.

Factors associated with bone metabolism in acromegalic patients: hypogonadism and female gender.

Tütüncü NB, Erbaş T.

Exp Clin Endocrinol Diabetes. 2004 Jun;112(6):328-32.

PMID:
15216451
47.

Diabetic autonomic neuropathy.

Vinik AI, Freeman R, Erbas T.

Semin Neurol. 2003 Dec;23(4):365-72. Review.

PMID:
15088257
48.

Metabolic syndrome.

Erbas T.

Acta Diabetol. 2003 Dec;40 Suppl 2:S401-4.

PMID:
14704875
49.

Recognizing and treating diabetic autonomic neuropathy.

Vinik AI, Erbas T.

Cleve Clin J Med. 2001 Nov;68(11):928-30, 932, 934-44. Review.

PMID:
11718432
50.

Platelet dysfunction in type 2 diabetes.

Vinik AI, Erbas T, Park TS, Nolan R, Pittenger GL.

Diabetes Care. 2001 Aug;24(8):1476-85. Review.

PMID:
11473089

Supplemental Content

Support Center